Skip to main content
. Author manuscript; available in PMC: 2019 Jun 26.
Published in final edited form as: J Cancer Educ. 2019 Jun;34(3):441–445. doi: 10.1007/s13187-018-1320-1

Table 1.

Patient characteristics (N=50)

Variable N (%) or M (SD)
Age 63.5 (7.5)
Race/ethnicity
 White 37 (74.0)
 Othera 13 (26.0)
Marital status
 Married 43 (86.0)
 Other 7 (14.0)
Education
 High school diploma 14 (28.0)
 Some college 12 (24.0)
 Bachelor’s degree 16 (32.0)
 Graduate degree 8 (16.0)
Years since date of biopsyb 3.6 (3.2)
Gleason score at diagnosisb 7.0 (0.9)
PSA score at diagnosisc 6.1 (3.4)
Stage of cancer at diagnosisd
 Stage I 5 (10.4)
 Stage II 36 (75.0)
 Stage III 7 (14.6)
Treatment type
 Prostatectomy 42 (84.0)
 Radiation 4 (8.0)
 Prostatectomy + radiation 2 (4.0)
 Active surveillance 2 (4.0)
General prostate cancer anxiety
 Yes 11 (22.0)
 No 39 (78.0)
PSA anxiety
 Yes 3 (6.0)
 No 47 (94.0)
Fear of recurrence
 Yes 43 (86.0)
 No 7 (14.0)
Health literacy (max score = 15) 12.9 (2.2)
GSS knowledge (max score = 4) 1.8 (1.4)
Perceived importance of the GSS (mean scale score) 2.8 (1.0)

Note: PSA = Prostate Specific Antigen. GSS = Gleason scoring system.

a

Racial/ethnic groups (Non-Hispanic Black=10, Asian=2, Hispanic = 1) collapsed into “other” due to low sample size

b

N=49

c

N=43

d

N=48